Depression and Cognition Mediate RBD Impact on Daily Living in Parkinson's Disease

Overview

This study demonstrates that depression and cognitive impairment independently and jointly mediate the negative impact of rapid eye movement sleep behavior disorder (RBD) on activities of daily living (ADL) in Parkinson's disease (PD) patients. The mediating effects of both depression and cognition increase over time, highlighting the progressive nature of these influences.

Background

Rapid eye movement sleep behavior disorder (RBD) is a common non-motor symptom in Parkinson's disease (PD) that exacerbates cognitive decline and depressive symptoms. These neuropsychiatric complications significantly impair patients' ability to perform activities of daily living (ADL). Understanding the pathways through which RBD affects ADL can inform targeted interventions to improve patient outcomes. This study investigates the mediating roles of depression and cognitive function in the relationship between RBD and ADL over time.

Data Highlights

Key Findings

• Depression mediates the relationship between RBD and ADL with increasing effect over time.
• Cognitive impairment also independently mediates the impact of RBD on ADL, with a similarly increasing trend.
• The combined mediating effect of depression and cognition is substantial, indicating a joint influence on ADL deterioration.
• Mediation effects were quantified at multiple standardized time points (0.25, 0.50, 0.75), showing progressive increases.
• Early intervention targeting depressive symptoms and cognitive decline may mitigate RBD-related ADL impairment in PD patients.

Clinical Implications

Clinicians should prioritize early screening and management of depression and cognitive dysfunction in PD patients exhibiting RBD to preserve daily functioning. Therapeutic strategies aimed at reducing depressive symptoms and enhancing cognitive performance may effectively attenuate the detrimental effects of RBD on activities of daily living. Monitoring these mediators over time can guide personalized care plans.

Conclusion

Depression and cognitive impairment serve as key mediators in the pathway from RBD to ADL decline in Parkinson's disease, with their influence intensifying as the disease progresses. Targeted interventions addressing these factors early in the disease course are crucial to improving patient quality of life.

References

1. Parkinson's Progression Markers Initiative (PPMI) -- The Role of Depression and Cognitive Function in Mediating the Impact of Rapid Eye Movement Sleep Behavior Disorder on Daily Living Activities in Parkinson's Disease Patients